Scientific Communications: secondary prevention 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION O - ESOC25-392 TIMING OF DOAC INITIATION AND MORTALITY 3 AND 12 MONTHS AFTER ACUTE ISCHEMIC STROKE: A NATIONAL OBSERVATIONAL STUDY Oskar Fasth 1 , Jonas Oldgren 1,2 , Tatevik Ghukasyan Lakic 2 , Ziad Hijazi 1,2 , Bo G
Unlike stimulants, theres no jitteriness, insomnia (DSIP actually improves sleep), appetite suppression, or cardiovascular strain
Improved Cardiovascular Health
#Neuroscience #NeuronGlia #DrugDiscovery #Neuropharmacology #DrugDevelopment #Neurodegeneration #BrainHealth #PharmaceuticalResearch To view or add a comment, sign in Recent research has identified specific brain circuits affected by psilocybin, the active compound in certain psychedelic mushrooms, which may offer new approaches for managing chronic pain and depression
Across New York City, more people are talking about peptide therapy